A Fully Human Monoclonal Antibody Targeting c-KIT is a Potent Inhibitor of Choroidal Neovascularization in Murine Model of Neovascular Age-Related Macular Degeneration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Songyi | - |
dc.contributor.author | Kim, Jin-Ock | - |
dc.contributor.author | Kim, Koung Li | - |
dc.contributor.author | Woo, Se Joon | - |
dc.contributor.author | Park, Sang Gyu | - |
dc.contributor.author | Suh, Wonhee | - |
dc.date.accessioned | 2022-01-26T01:42:12Z | - |
dc.date.available | 2022-01-26T01:42:12Z | - |
dc.date.issued | 2021-06 | - |
dc.identifier.issn | 0146-0404 | - |
dc.identifier.issn | 1552-5783 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54460 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | - |
dc.title | A Fully Human Monoclonal Antibody Targeting c-KIT is a Potent Inhibitor of Choroidal Neovascularization in Murine Model of Neovascular Age-Related Macular Degeneration | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, v.62, no.8 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000690760500211 | - |
dc.citation.number | 8 | - |
dc.citation.title | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | - |
dc.citation.volume | 62 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | 미국 | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.